Improving depression treatment for cancer patients using technology
Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers
['FUNDING_R01'] · UNIVERSITY OF WASHINGTON · NIH-10891410
This study is looking to improve how we help cancer patients deal with depression by adding mental health support right into their cancer care, making it easier for everyone, no matter where they live, to get the help they need.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10891410 on ClinicalTrials.gov |
What this research studies
This research aims to enhance the treatment of depression among cancer patients, who often experience significant mental health challenges. By implementing Collaborative Care Management (CoCM), the project seeks to integrate behavioral health support into cancer care, addressing barriers such as access to mental health professionals and logistical issues. The approach involves care managers who will provide behavioral treatments and coordinate psychosocial support, ensuring that patients receive comprehensive care tailored to their needs. The study focuses on both urban and rural cancer centers to ensure equitable access to mental health resources.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients experiencing symptoms of depression, particularly those in urban and rural settings.
Not a fit: Patients who are not currently undergoing cancer treatment or do not have a diagnosis of depression may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved mental health outcomes and quality of life for cancer patients suffering from depression.
How similar studies have performed: Previous research has shown that Collaborative Care Management can significantly improve depression symptoms in various patient populations, indicating a promising approach for this study.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FANN, JESSE R — UNIVERSITY OF WASHINGTON
- Study coordinator: FANN, JESSE R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.